Tomatidine reduces Chikungunya virus progeny release by controlling viral protein expression
Open Access
- 11 November 2021
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 15 (11) , e0009916
Abstract
Tomatidine, a natural steroidal alkaloid from unripe green tomatoes has been shown to exhibit many health benefits. We recently provided in vitro evidence that tomatidine reduces the infectivity of Dengue virus (DENV) and Chikungunya virus (CHIKV), two medically important arthropod-borne human infections for which no treatment options are available. We observed a potent antiviral effect with EC50 values of 0.82 μM for DENV-2 and 1.3 μM for CHIKV-LR. In this study, we investigated how tomatidine controls CHIKV infectivity. Using mass spectrometry, we identified that tomatidine induces the expression of p62, CD98, metallothionein and thioredoxin-related transmembrane protein 2 in Huh7 cells. The hits p62 and CD98 were validated, yet subsequent analysis revealed that they are not responsible for the observed antiviral effect. In parallel, we sought to identify at which step of the virus replication cycle tomatidine controls virus infectivity. A strong antiviral effect was seen when in vitro transcribed CHIKV RNA was transfected into Huh7 cells treated with tomatidine, thereby excluding a role for tomatidine during CHIKV cell entry. Subsequent determination of the number of intracellular viral RNA copies and viral protein expression levels during natural infection revealed that tomatidine reduces the RNA copy number and viral protein expression levels in infected cells. Once cells are infected, tomatidine is not able to interfere with active RNA replication yet it can reduce viral protein expression. Collectively, the results delineate that tomatidine controls viral protein expression to exert its antiviral activity. Lastly, sequential passaging of CHIKV in presence of tomatidine did not lead to viral resistance. Collectively, these results further emphasize the potential of tomatidine as an antiviral treatment towards CHIKV infection.Keywords
Funding Information
- Graduate School of Medical Sciences at the University of Groningen
- Cock grant hadders stichting
- University Medical Center Groningen
- University Medical Center Groningen
This publication has 42 references indexed in Scilit:
- Identification of Novel Compounds Inhibiting Chikungunya Virus-Induced Cell Death by High Throughput Screening of a Kinase Inhibitor LibraryPLOS Neglected Tropical Diseases, 2013
- Characterization of Synthetic Chikungunya Viruses Based on the Consensus Sequence of Recent E1-226V IsolatesPLOS ONE, 2013
- Tomatidine, a Tomato Sapogenol, Ameliorates Hyperlipidemia and Atherosclerosis in ApoE-Deficient Mice by Inhibiting Acyl-CoA:cholesterol Acyl-transferase (ACAT)Journal of Agricultural and Food Chemistry, 2012
- In vitro antiviral activity of arbidol against Chikungunya virus and characteristics of a selected resistant mutantAntiviral Research, 2011
- Biology and pathogenesis of chikungunya virusNature Reviews Microbiology, 2010
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009
- Effect of host cell lipid metabolism on alphavirus replication, virion morphogenesis, and infectivityProceedings of the National Academy of Sciences, 2008
- Tomatidine inhibits iNOS and COX‐2 through suppression of NF‐κB and JNK pathways in LPS‐stimulated mouse macrophagesFEBS Letters, 2008
- Ribavirin therapy for Chikungunya arthritisThe Journal of Infection in Developing Countries, 2008
- Infectious Clones of Chikungunya Virus (La Réunion Isolate) for Vector Competence StudiesVector-Borne and Zoonotic Diseases, 2006